Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-11-04

FDA Approved: ESZOPICLONE — Supplemental Application (Mylan Pharmaceuticals Inc.)

View source ↗

Summary

The FDA approved a supplemental application from Mylan Pharmaceuticals for eszopiclone (generic), under ANDA 091151, to support the marketing of an eszopiclone …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Eszopiclone (eszopiclone)

Snippet

SUPPL AP for ESZOPICLONE (ESZOPICLONE)